AbCellera Biologics (ABCL) EBT Margin (2020 - 2026)
AbCellera Biologics (ABCL) reported EBT Margin of -1455.93% for Q2 2026, down 1243.19 percentage points from -212.74% a year earlier and down 860.17 percentage points from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) EBT Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AbCellera Biologics' EBT Margin came in at -297.36%, up 307.31 percentage points year-over-year; for FY2025, it came in at -236.39%, up 458.63 percentage points from FY2024.
- EBT Margin has a five-year change of -304.08 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -695.02% in FY2024 (-237.35 pp), -457.67% in FY2023 (-506.93 pp), 49.26% in FY2022 (-9.15 pp) and 58.41% in FY2021 (-9.29 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBT Margin in data going back to Q1 2020.
- Year over year, EBT Margin gained in four of the last eight quarters, with an average year-over-year change of -81.37 percentage points.
- The high point for year-over-year EBT Margin in five years was Q4 2025 (a gain of 883.83 percentage points); the low point was Q2 2026 (a drop of 1243.19 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -595.75% (Q1 2026), -43.47% (Q4 2025) and -767.93% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.47 Bn | 1,126.05 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 624.23 Bn | 542.75 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 513.86 Bn | 486.97 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 365.96 Bn | 320.33 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.62 Bn | 261.61 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.86 Bn | 235.54 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 235.46 Bn | 190.86 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 193.77 Bn | 167.96 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 172.08 Bn | 118.73 Bn | 10.94 Bn | -4.34% |
| 10 | AbCellera Biologics | 3.57 Bn | 3.03 Bn | - | -1,455.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,455.93% |
| Mar 31, 2026 | -595.75% |
| Dec 31, 2025 | -43.47% |
| Sep 30, 2025 | -767.93% |
| Jun 30, 2025 | -212.74% |
| Mar 31, 2025 | -1,251.10% |
| Dec 31, 2024 | -927.31% |
| Sep 30, 2024 | -962.53% |
| Jun 30, 2024 | -658.02% |
| Mar 31, 2024 | -429.45% |
| Dec 31, 2023 | -529.49% |
| Sep 30, 2023 | -595.18% |
| Jun 30, 2023 | -377.92% |
| Mar 31, 2023 | -394.91% |
| Dec 31, 2022 | -145.80% |
| Sep 30, 2022 | 45.95% |
| Jun 30, 2022 | -15.00% |
| Mar 31, 2022 | 72.91% |
| Dec 31, 2021 | 60.80% |
| Sep 30, 2021 | -453.38% |
API Access
AbCellera Biologics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();